vs
NATURES SUNSHINE PRODUCTS INC（NATR）とGIBRALTAR INDUSTRIES, INC.（ROCK）の財務データ比較。上の社名をクリックして会社を切り替えられます
GIBRALTAR INDUSTRIES, INC.の直近四半期売上が大きい（$225.0M vs $123.8M、NATURES SUNSHINE PRODUCTS INCの約1.8倍）。GIBRALTAR INDUSTRIES, INC.の前年同期比売上増加率が高い（24.9% vs 4.7%）。GIBRALTAR INDUSTRIES, INC.の直近四半期フリーキャッシュフローが多い（$26.2M vs $7.6M）。過去8四半期でNATURES SUNSHINE PRODUCTS INCの売上複合成長率が高い（5.6% vs -12.3%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
ジブラルタル・インダストリーズ社は、特殊建築資材、インフラ関連製品、再生可能エネルギー向け製品の製造・販売を行う有力企業です。換気システム、屋根用付属品、太陽光発電設置架台、造園用品などを取り扱い、主に北米の住宅・商業建設、クリーンエネルギー市場向けにサービスを提供しています。
NATR vs ROCK — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $123.8M | $225.0M |
| 純利益 | $4.1M | — |
| 粗利率 | 72.5% | 25.3% |
| 営業利益率 | 4.3% | 7.9% |
| 純利益率 | 3.3% | — |
| 売上前年比 | 4.7% | 24.9% |
| 純利益前年比 | 1379.4% | — |
| EPS（希薄化後） | $0.23 | — |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $123.8M | $225.0M | ||
| Q3 25 | $128.3M | $310.9M | ||
| Q2 25 | $114.8M | $309.5M | ||
| Q1 25 | $113.2M | $290.0M | ||
| Q4 24 | $118.2M | $180.1M | ||
| Q3 24 | $114.6M | $277.1M | ||
| Q2 24 | $110.6M | $273.6M | ||
| Q1 24 | $111.0M | $292.5M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $-89.1M | ||
| Q2 25 | $5.3M | $26.0M | ||
| Q1 25 | $4.7M | $21.1M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | $34.0M | ||
| Q2 24 | $1.3M | $32.2M | ||
| Q1 24 | $2.3M | $24.9M |
| Q4 25 | 72.5% | 25.3% | ||
| Q3 25 | 73.3% | 26.6% | ||
| Q2 25 | 71.7% | 28.4% | ||
| Q1 25 | 72.1% | 26.8% | ||
| Q4 24 | 72.0% | 29.0% | ||
| Q3 24 | 71.3% | 29.4% | ||
| Q2 24 | 71.4% | 30.5% | ||
| Q1 24 | 71.2% | 28.9% |
| Q4 25 | 4.3% | 7.9% | ||
| Q3 25 | 7.0% | 12.8% | ||
| Q2 25 | 3.7% | 12.8% | ||
| Q1 25 | 5.4% | 8.8% | ||
| Q4 24 | 3.8% | 13.3% | ||
| Q3 24 | 4.6% | 15.6% | ||
| Q2 24 | 5.1% | 14.9% | ||
| Q1 24 | 4.2% | 10.8% |
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | -28.6% | ||
| Q2 25 | 4.6% | 8.4% | ||
| Q1 25 | 4.2% | 7.3% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | 12.3% | ||
| Q2 24 | 1.2% | 11.8% | ||
| Q1 24 | 2.1% | 8.5% |
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.30 | $-2.98 | ||
| Q2 25 | $0.28 | $0.87 | ||
| Q1 25 | $0.25 | — | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $0.23 | $1.11 | ||
| Q2 24 | $0.07 | $1.05 | ||
| Q1 24 | $0.12 | — |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $93.9M | $115.7M |
| 総負債低いほど良い | — | $0 |
| 株主資本純資産 | $161.6M | $950.4M |
| 総資産 | $261.1M | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $93.9M | $115.7M | ||
| Q3 25 | $95.6M | $89.4M | ||
| Q2 25 | $81.3M | $43.3M | ||
| Q1 25 | $86.5M | $25.1M | ||
| Q4 24 | $84.7M | $269.5M | ||
| Q3 24 | $78.7M | $228.9M | ||
| Q2 24 | $68.7M | $179.1M | ||
| Q1 24 | $77.8M | $146.7M |
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | $2.1M | $0 |
| Q4 25 | $161.6M | $950.4M | ||
| Q3 25 | $166.7M | $951.8M | ||
| Q2 25 | $163.7M | $1.0B | ||
| Q1 25 | $167.1M | $1.0B | ||
| Q4 24 | $161.0M | $1.0B | ||
| Q3 24 | $162.6M | $1.0B | ||
| Q2 24 | $156.4M | $975.7M | ||
| Q1 24 | $159.7M | $940.2M |
| Q4 25 | $261.1M | $1.4B | ||
| Q3 25 | $264.8M | $1.4B | ||
| Q2 25 | $254.9M | $1.5B | ||
| Q1 25 | $252.7M | $1.4B | ||
| Q4 24 | $240.9M | $1.4B | ||
| Q3 24 | $245.3M | $1.4B | ||
| Q2 24 | $235.8M | $1.4B | ||
| Q1 24 | $247.3M | $1.3B |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | 0.01× | 0.00× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | $35.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $7.6M | $26.2M |
| FCFマージンFCF / 売上 | 6.1% | 11.7% |
| 設備投資強度設備投資 / 売上 | 1.9% | 4.1% |
| キャッシュ転換率営業CF / 純利益 | 2.41× | — |
| 直近12ヶ月FCF直近4四半期 | $28.8M | $120.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $9.9M | $35.5M | ||
| Q3 25 | $18.5M | $73.0M | ||
| Q2 25 | $4.3M | $44.9M | ||
| Q1 25 | $2.6M | $13.7M | ||
| Q4 24 | $12.2M | $19.9M | ||
| Q3 24 | $9.6M | $64.7M | ||
| Q2 24 | $1.3M | $36.5M | ||
| Q1 24 | $2.2M | $53.2M |
| Q4 25 | $7.6M | $26.2M | ||
| Q3 25 | $16.8M | $64.8M | ||
| Q2 25 | $3.0M | $27.3M | ||
| Q1 25 | $1.5M | $2.3M | ||
| Q4 24 | $10.0M | $14.1M | ||
| Q3 24 | $7.9M | $60.5M | ||
| Q2 24 | $-2.0M | $33.5M | ||
| Q1 24 | $-1.5M | $48.8M |
| Q4 25 | 6.1% | 11.7% | ||
| Q3 25 | 13.1% | 20.8% | ||
| Q2 25 | 2.6% | 8.8% | ||
| Q1 25 | 1.3% | 0.8% | ||
| Q4 24 | 8.5% | 7.8% | ||
| Q3 24 | 6.9% | 21.8% | ||
| Q2 24 | -1.9% | 12.2% | ||
| Q1 24 | -1.4% | 16.7% |
| Q4 25 | 1.9% | 4.1% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 1.2% | 5.7% | ||
| Q1 25 | 1.0% | 3.9% | ||
| Q4 24 | 1.9% | 3.3% | ||
| Q3 24 | 1.5% | 1.5% | ||
| Q2 24 | 3.0% | 1.1% | ||
| Q1 24 | 3.3% | 1.5% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | 1.73× | ||
| Q1 25 | 0.55× | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | 1.90× | ||
| Q2 24 | 0.97× | 1.13× | ||
| Q1 24 | 0.94× | 2.13× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
